Magnetic particle imaging performance of liposomes encapsulating iron oxide nanoparticles

Superparamagnetic α-Fe2O3/Fe3O4 Heterogeneous Nanoparticles with Enhanced Biocompatibility

“…Although MFe 2 O 4 nanoparticles have exhibited excellent characteristics in the biomedical field, their safe application in the human body is a major problem owing to the heavy metal elements presented in MFe 2 O 4 [ 1 ], which also limits their applications in the biomedical field. So, as one of the typical nanomaterials, spinel iron oxide nanoparticles without heavy metal elements have been widely applied in many aspects of the biomedicine field due to their good biocompatibility and no toxicity or low toxicity in organisms [ 2 , 3 ], such as magnetic resonance imaging (MRI) [ 4 ], clinical diagnosis and the treatment of diseases [ 5 , 6 ], magnetic carriers for drug targeting [ 7 ], catalysis [ 8 , 9 , 10 , 11 , 12 ], immune assays [ 13 ], targeting photodynamic therapy [ 14 , 15 , 16 ], cell separation [ 17 ], DNA extraction [ 18 ], and so on. Therefore, the preparations and applications of iron oxide nanoparticles have attracted more and more researchers [ 19 , 20 ].…”

Magnetically responsive, sorafenib loaded alginate microspheres for hepatocellular carcinoma treatment

“…Besides, the zeta potential of SPIONs was found out as −27.0 mV that means SPIONs were moderately stable (Fig. 3) [19].…”

Magnetic particle imaging: tracer development and the biomedical applications of a radiation-free, sensitive, and quantitative imaging modality

“…165 The improved magnetic moment demonstrates advantages in standard magnetic hyperthermia techniques, [173][174][175][176][177] Please do not adjust margins Please do not adjust margins coupled magnetic fluid hyperthermia (MFH), otherwise called MPI-MFH. [178][179][180][181] The benefits of MPI-MFH is discussed in depth in section 5.2.2. The shape of the core, or cores in the case of a multi-core formulation, is another factor that demonstrates strong influence over SPION performance in MPI.…”